Loading
Latest filing published 18 Oct 2022 for Lexaria Bioscience Corp., €259.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Gregory Downey in Lexaria Bioscience Corp. Activity is concentrated on a single trading day, 14 October 2022, with 2 filings.
Purchases make up the whole of the open-market record (1 purchase, €259). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
The record was last updated on 18 October 2022 with an open-market purchase (€259) in Lexaria Bioscience Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration